The extent to which congestive heart failure (CHF) is dependent upon increased levels of the cardiac inhibitory GTP-binding protein (Gi), and the impact of CHF on the cardiac stimulatory GTP-binding protein (Gs) and mechanisms by which Gs may change remain unexplored. We have addressed these unsettled issues using pacing-induced CHF in pigs to examine physiological, biochemical, and molecular features of the right atrium (RA) and left ventricle (LV). CHF was associated with an 85±20% decrease in LV segment shortening (P < 0.001) and a 3.5-fold increase (P = 0.006) in the ED5, for isoproterenol-stimulated heart rate responsiveness. Myocardialfg-adrenergic receptor number was decreased 54% in RA (P = 0.004) and 57% in LV (P < 0.001), and multiple measures of adenylyl cyclase activity were depressed 49±8% in RA (P < 0.005), and 44±9% in LV (P < 0.001). Quantitative immunoblotting established that Gi and Gs were decreased in RA (Gi: 59% reduction; P < 0.0001; Gs: 28% reduction; P < 0.007) and LV (Gi: 35% reduction; P < 0.008; Gs: 28% reduction; P < 0.01 ) after onset of CHF. Reduced levels of Gi and Gs were confirmed by ADP ribosylation studies, and diminished function of Gs was established in reconstitution studies. Steady state levels for Gsa mRNA were increased in RA and unchanged in LV, and significantly more GSa was found in the supernatant (presumably cytosolic) fraction in RA and LV membrane homogenates after CHF, suggesting that increased Gs degradation, rather than decreased Gs synthesis, is the mechanism by which Gs is downregulated. We conclude that cardiac Gi content poorly predicts adrenergic responsiveness or contractile function, that decreased Gs is caused by increased degradation rather than decreased synthesis, and that alterations in fI-adrenergic receptors, adenylyl cyclase, and GTP-binding proteins are uniform in RA and LV in this model of congestive heart failure. (J. Clin. Invest. 1993. 91:939-949.)
Introduction
In 1962 Whipple et al. ( 1 ) , developed an animal model ofheart failure analogous to heart failure associated with chronic atrial arrhythmias in humans. They were able to achieve a state of venous congestion and cardiac enlargement in dogs after 3-4 wk of continuous rapid atrial pacing. A subsequent paper by Coleman et al. (2) , 9 yr later, established that rapid ventricular pacing in dogs was associated with marked abnormalities in left ventricular (LV)' systolic function. After a 15-yr dormancy, this model resurfaced (3) (4) (5) . This resurrection was due in part to the burgeoning interest in molecular and biochemical alterations associated with heart failure, but also reflected the simplicity and consistency of this model in comparison to others. Pacing-induced cardiac dysfunction is now a much-used animal model for the study of heart failure (6) (7) (8) (9) (10) .
Despite recent publications regarding various aspects ofcardiac function in pacing-induced heart failure, certain important areas remain unexplored. First, the effects ofchronic rapid ventricular pacing upon the stimulatory (Gs) and inhibitory (Gi) GTP-binding proteins in the right atrium (RA) are unknown. Our laboratory has an interest in heart rate regulation and chamber-specific changes in signal transduction in the heart ( 1 1-14). Since a major means for increasing cardiac output in severe heart failure is by increasing heart rate, factors affecting heart rate regulation are important. Second, what little attention that has been focused upon Gi-mediated events in the setting of pacing-induced heart failure have provided discordant data (6, 7) . Furthermore, the extent to which heart failure is dependent upon increased levels of cardiac Gi is unknown. Finally, the impact of heart failure upon cardiac Gs and potential mechanisms by which Gs may change remain almost completely unexplored.
Human congestive heart failure (CHF) has been associated with increased levels of Gi in the LV (15) (16) (17) . It has been postulated that increased Gi may contribute to the inability of the heart to respond to adrenergic stimulation, and therefore may be of pathophysiological importance in CHF. This infers that basal levels ofcardiac Gi can negatively influence 3-adrenergic receptor (fAR)-stimulated adenylyl cyclase activity, and suggests that increased cardiac Gi content may contribute to decreased adenylyl cyclase activity. The degree to which cardiac Gi content influences the stimulation of adenylyl cyclase through the fAR-Gs-mediated pathway, however, has not been precisely defined. Simply put, is an increase in cardiac Gi content necessary or sufficient for abnormalities in contractile function?
We have undertaken this study to address these unsettled issues, and to test these hypotheses: (a) Pacing-induced CHF will be associated with increased Gi content and decreased Gs activity in both RA and LV; and (b) decreased Gs activity will be associated with decreased steady state levels of Gs a mRNA, suggesting that downregulation of cardiac Gs is caused by decreased synthesis of the protein.
Methods
Animals, instrumentation, and pacing protocol. Experimental animals included 17 pigs (sus scrofa), 50±8 kg (mean± 1 SD). 15 control pigs (51 ± 16 kg) were examined as well. Seven of these animals underwent thoracotomy and instrumentation but no pacing, and myocardium from these animals underwent biochemical and molecular analyses. The other eight control animals were included in analysis of heart and liver weights (Table I) . After acclimatization to human handling, animals received ketamine (50 mg/kg, intramuscularly) and atropine sulfate (0.1 mg/kg, intramuscularly) followed by sodium amytal (100 mg/kg, intravenously). Animals underwent endotracheal intubation and halothane (0.5-1.5%) was delivered by a pressure cycled ventilator for the duration of the surgical procedure. Left thoracotomy was performed, and catheters placed in the aorta, pulmonary artery, and left atrium. An ultrasonic crystal micrometer was placed (segment orientation) in the midwall ofthe anterior free wall ofthe LV, 2.0 cm from the base of the heart, midway between the left anterior descending and its first diagonal branch. An epicardial unipolar lead was placed 1.0 cm below the atrioventricular groove in the LV. The power generator (Spectrax 5985; Medtronic Inc., Minneapolis, MN) was placed in a subcutaneous pocket in the abdomen. After recovery from thoracotomy, animals underwent initial pharmacological and hemodynamic measurements (see below). Rapid ventricular pacing then was initiated (220 bpm for 7 d; 240 bpm subsequently). Hemodynamic tests were obtained every 7 d thereafter, with pacemakers inactivated for 1 h before acquisition of data. Pacers were returned to their pretest rates immediately after data collection. After signs of circulatory congestion developed and substantial hemodynamic abnormalities were present, pharmacological tests were repeated and animals were killed 31±7 d after initiation of pacing.
Isoproterenol-stimulated chronotropic response. After recovery from thoracotomy ( 14 d), animals underwent pharmacological testing using (-)isoproterenol ( 1) . The animals were placed in a sling, and bolus doses of isoproterenol (0.05-2.0 ug/kg) were given through a venous catheter while heart rate and arterial blood pressure were measured. Since heart failure may affect reflex activation independently of changes in myocardial 3AR responsiveness, all experiments were conducted in the presence of glycopyrrolate (0. 14 mg/kg, intravenously), a long-acting muscarinic cholinergic antagonist ( 18) , thereby isolating cardiac fAR responsiveness to an optimal degree. The dose of glycopyrrolate was selected from pilot studies; the absence of changes in heart rate in response to nitroglycerine-induced hypotension was used as a criterion for successful suppression ofvagally mediated reflex modulation. The possibility of acute desensitization induced by isoproterenol during this protocol was a concern. To assess for acute desensitization, protocols began and ended with the administration of a bolus injection of a near maximal dose of isoproterenol (1.0 ,g/kg); final heart rate response was not > 5% less than the initial response, so we assumed that desensitization during isoproterenol testing did not occur. Pharmacological tests were repeated 25±5 d after initiation ofpacing, when signs ofcirculatory congestion (tachycardia, tachypnea) and myocardial dysfunction (depressed fractional shortening, increased left atrial pressure) had developed. Data were examined by nonlinear regression analyses of the relationship between logarithm of isoproterenol dose and heart rate change. We have shown previously that thoracotomy alone does not affect the heart rate responsiveness to isoproterenol stimulation ( 11).
Terminal surgery. After 31±7 d ofcontinuous pacing, and 48-72 h after completion of all pharmacological and physiological tests, animals were anesthetized, intubated, and midline sternotomies made. The heart was removed, rinsed in sterile saline (4°C), and the coronary arteries rapidly perfused with sterile saline (40C). The RA, left atrium, and right ventricular (RV) free wall were removed. The RV, LV, and septum were weighed. RA samples were obtained from identical regions in all animals. Transmural samples of LV free wall were taken midway from base to apex, near the midportion of the left anterior descending coronary artery. Myocardial samples were then frozen (-80'C). Time from heart removal to placing samples in liquid nitrogen was 5-10 min.
Membrane preparation. Frozen (-80'C) transmural samples were powdered in a stainless steel mortar and pestle (also -800C), placed in Tris buffer, glass-glass homogenized, and contractile proteins extracted (0.5 M KCl, 20 min, 40C). The pellet of a 45,000 g centrifugation was resuspended in buffer and radioligand binding experiments, adenylyl cyclase studies, and reconstitution studies performed. f3-adrenergic receptor binding studies. fl-adrenergic receptors were identified using the radioligand [ '25I ]iodocyanopindolol (ICYP; 5-700 pM) in saturation isotherm experiments conducted on crude membrane preparations as previously described (1 1, 19) . Protein concentrations were determined by the method of Bradford (20) , and assessment ofmembrane protein yield per mg crude membrane homogenate was performed using the cardiac sarcolemmal membrane marker, K+-stimulated p-nitrophenylphosphatase, after the method of Bers (21 ) . Previous experiments have established that 3 receptors are not lost to the supernatant in our membrane preparations and that O3AR number is unaffected by thoracotomy alone (1 1, 19) .
Adenylyl cyclase assays. Methods were modified from Salomon (22) as previously reported ( 13, 19) . The following agents were used to stimulate cAMP production (final concentrations): isoproterenol (10 MuM), Gpp[NH]p ( 100MgM), NaF ( 10 mM), forskolin ( 100 ,M)..We found that cAMP production under these conditions was linear with respect to time and protein concentration, and that 3-isobutyl, 2-methylxanthine ( 1.0 mM), adenosine deaminase (5 U/ml), or both, had no effect on basal or maximally stimulated cAMP production. Previous experiments established that adenylyl cyclase activity does not distribute to the supernatant of a 45,000 g centrifugation in our membrane preparation, and that thoracotomy alone does not influence adenylyl cyclase activity ( 19) .
Bacterial toxin-catalyzedADP-ribosylation. Cholera toxin and pertussis toxin were preactivated in 20 mM Hepes-buffer ( Gsa; AS/7, transducin, Gial, Gia2; New England Nuclear, Boston, MA) were diluted 1:600 in 15 ml ofTBS with 0.05% Tween-20 (TTBS, pH 7.5) and 1% nonfat dry milk, and membranes incubated for 14 h, 4°C (28). Autoradiographic detection of bands was performed by incubating membranes in 75 ml TTBS with 1% nonfat dry milk and 15 X 106 cpm '251I-protein A (New England Nuclear) for 2 h, 25°C followed by thorough sequential washes in TTBS, and placing against x-ray film (Kodak X-OMAT AR) for 5 d, -70°C. The 45-and 3 1-kD bands for Gsa and GST-GsF7, respectively, were removed from the membranes with background controls for gamma counting. Likewise, the 40-and 30-kD bands for GiaI, Gia2, and GST-Gi2F7, respectively, were removed and counted. Using the specific activity of the GST-fusion protein standards and the specific activity of the sample bands of interest, the tissue GTP-binding protein content was calculated. Gsa and Gia2 cDNA were provided by Dr. A. Gilman (Texas Health Sciences Center, Dallas, TX) and Dr. Kaziro (Tokyo University, Japan).
Reconstitution assay for Gs. We modified a reconstitution assay for use with porcine myocardial membranes (29) as previously described ( 13, 19) . Reconstitution assays were performed on undiluted 1% cholate extract, and several serial dilutions, giving a wide range of protein content. We have found that intrinsic adenylyl cyclase activity in extract and cyc-membranes is negligible, and that NaF stimulation of cyc-membranes yields no cAMP production. In preliminary studies we found cAMP production to be proportional to amount ofextract added (from 1 to 120 Ag), and the rate of cAMP synthesis is linear with time for 40 min. We performed assays on extracts from experimental animals side-by-side with appropriate control extracts, using the same batch ofcyc-membranes, to minimize the potential confounding influence ofvariation in catalytic subunit concentration in cyc-membranes. Data are expressed as picomoles cAMP produced per 10 minutes as a function of membrane protein used.
Plasma and tissue catecholamine measurements. Blood samples were obtained from animals in the basal state 2 wk after initial thoracotomy, and again just before killing, after CHF was present. Levels of epinephrine and norepinephrine in plasma and myocardium were determined using a sensitive radioenzymatic assay previously described (30) , and data are expressed as catecholamine per milligram wet weight of tissue or per milliliter plasma.
Northern blot analysis. Total RNA was extracted from RA and LV using the RNazol method. 20-,ug samples, measured spectrophotometrically, were separated by electrophoresis ( 14 h, 30 V) in a formaldehyde 1.2% agarose gel. Equal RNA loading was confirmed photographi- 5+3 § Data were collected from conscious animals at rest 60 min after disabling the pacemakers. * P < 0.01; * P < 0.001; § P < 0.05 (vs control values). LAP, mean left atrial pressure, PA, mean pulmonary arterial pressure, Ao, mean aortic pressure, % SEG = percent segment shortening.
cally by ethidium bromide staining and ultraviolet detection. The gel was blotted to nylon membrane and baked for 2 h (80°C). The membrane was hybridized overnight at 55°C with the 32P-labeled riboprobe (antisense mRNA, 5 X 106 cpm/ml) and exposed to x-ray film (-70°C, 4 h). The film was then assessed by densitometry (390 gel densitometer; Hoefer Scientific Instruments, San Francisco, CA). Statistics. Data are expressed as mean±1 SD. Specific measurements were compared before and after induction of heart failure in each animal using Student's t test for paired data; data from control vs CHF animals were compared using Student's t test for unpaired data. The null hypothesis was considered unlikely when P < 0.10, and rejected when P < 0.05 (two tailed).
Results
Characterization of the model. Table I and Fig. 1 show the hemodynamic and LV functional abnormalities associated with chronic rapid ventricular pacing. These data were obtained from conscious, unsedated animals. 1 wk after initiation of pacing, animals had increased basal heart rates, and increased left atrial and pulmonary arterial pressures. Pressures became progressively more abnormal with additional weeks of pacing (Table I) . Signs of circulatory congestion (tachypnea, pulmonary rales, ascites) were evident in most experimental animals by the second or third week of pacing. These data establish that severely abnormal cardiac function resulted from 3 to 4 wk of rapid ventricular pacing. Tracking these abnormal hemodynamics and signs ofcongestion was progressive deterioration of LV systolic function (Fig. 1 ). Cardiac output decreased from 4.9±0.5 to 2.8±0.5 liters/min (P < 0.001). LV segment fractional shortening, an ejection phase index of LV systolic function, declined progressively during the course of the study. By week 3, there was an 85±20% decrease in segment shortening compared to the prepacing value (P < 0.001 ). The LV end-systolic pressure-dimension ratio, used to assess LV function in a relatively load-independent manner, was reduced at week 3 (control Torr/mm; P < 0.001), establishing that LV contractility was decreased. Assuming a spherical LV geometry, end-diastolic volume increased 95±10% (P < 0.001).
At necropsy animals had ascites (mean amount: 2,114 ml; range: 300-14,500 ml); and dilated, thin walled hearts, with all four chambers appearing grossly enlarged. Ventricular to body weight ratios suggested hypertrophy ofthe RV only (Table II ). An additional measure of the congested state was liver weight, which increased nearly twofold (Table II) . Plasma and myocardial catecholamine content. Fig. 2 shows that 4-5 wk after initiation of pacing, animals had increased levels of plasma norepinephrine (CON: 191±50 pg/ ml; CHF: 840±483 pg/ml; P = 0.05) and epinephrine (CON: 36±30 pg/ml; CHF: 80±46 pg/ml; P = 0.05). In addition, compared to the control state, myocardial levels ofnorepinephrine were reduced both in RA (CON: 5.2±1.8 ng/mg; CHF: 1.4±0.3 ng/mg; P = 0.002) and LV (CON: 2.5±0.8 ng/mg; CHF: 1.5±1.0 ng/mg; P = 0.05).
Isoproterenol-stimulated chronotropic response. Fig. 3 shows results of studies examining the ability of graded bolus doses of ( -)isoproterenol to increase heart rate. These studies were performed before and after development of CHF in 10 animals. Basal heart rate increased (CON: 109±16 bpm; CHF: 143±19 bpm; P = 0.001), maximal isoproterenol-stimulated heart rate decreased (CON: 256±17 bpm; CHF: 192±12 bpm; P < 0.0001 ), and maximal isoproterenol-stimulated change in heart rate decreased (CON: 1 19±23 bpm; CHF: 38±18 bpm; P < 0.0001 ). As shown in Fig. 3 , isoproterenol ED50 for heart rate change was increased 3.5-fold after heart failure had developed figure) was increased, and the maximal heart rate change was reduced (right side of figure) after signs of heart failure had developed. Open bars represent mean values before pacing (pre-CHF); cross-hatched bars represent mean values after congestive heart failure had developed (CHF); error bars denote 1 SD (n = 10). (CON: 0.07±0.02,gg/kg; CHF: 0.25±0.17,ug/kg; P = 0.006).
Finally, the slope-relating dose of isoproterenol with heart rate change was decreased after CHF (CON: 69±16; CHF: 34±20; P < 0.001). These data establish that cardiac f3AR responsiveness to isoproterenol is markedly diminished in animals with pacing-induced CHF. f3-adrenergic receptor binding studies. Fig. 4 shows the results of saturation isotherm experiments performed in seven control and seven CHF animals. Data shown were obtained from a mean of three saturation isotherms per tissue per animal, performed with triplicate points for each of eight concentrations of ICYP. 3AR number was decreased after pacing-induced CHF. The extent of flAR downregulation was 54% in RA (CON: 80±27 fmol/mg; CHF: 37±10 fmol/mg; P = 0.004), and 52% in LV(CON: 93±17 fmol/mg;CHF45±13 fmol/mg; P < 0.001). Kd for ICYP was invariant with pacinginduced CHF in membranes from RA (CON: 68±17 pM; CHF: 80±27 pM) and LV (CON: 81±22 pM; CHF: 97±44 pM). Mean r2 values for the Scatchard analyses were 0.96±0.04.
We were concerned that fibrosis or focal hypertrophy might alter sarcolemmal membrane yield after the induction of heart failure, thereby potentially artifactually lowering receptor number. We therefore used the specific activity of K+-pNPPase as a marker for sarcolemmal membrane (21) to confirm that expression of receptor binding per milligram protein was an appropriate means to measure loss of receptors. There was no significant difference in specific activities of this marker between crude membrane homogenates from control and paced animals either in RA (CON: 513±28 nmol/mg per h; CHF: 505±43 nmol/mg per h) or LV membranes (CON: 461±37 nmol/mg per h; CHF: 423±22 nmol/mg per h).
Adenylyl cyclase activity. OAR-dependent and Gs-dependent stimulation ofadenylyl cyclase were diminished markedly in RA and LV membranes from pigs after congestive heart failure ( Table III) . Basal values were lower in RA and LV membranes after CHF. Whether stimulated through the OAR, through Gs, or more directly through the catalytic subunit of adenylyl cyclase, net cAMP production was diminished. The mean reduction in cAMP production in RA membranes was 49±8% (range: 36-58%), the mean reduction in LV membranes was 44±9% (range: 35-57%).
Assessment of Gi. To determine whether diminution in adenylyl cyclase activity in myocardial membranes from paced animals was associated with increased levels of cardiac Gi, we used two independent measures: pertussis toxin-mediated ADP-ribosylation and quantitative immunoblotting (Fig. 5) . We found that pertussis toxin-catalyzed incorporation of 32P was reduced in RA membranes (CON: 18.0±2.6 pmol/g wet wt; CHF: 8.6±1.4 pmol/g wet wt; P < 0.005) and in LV membranes from animals with heart failure (CON: 13.4±2.4 pmol/ g; CHF: 8.3±4.2 pmol/g; P = 0.03). As an independent, and more specific assay for the assessment ofthe amount ofGia2 in cardiac membranes, we used quantitative immunoblotting (Fig. 5) which also showed reduced amounts in RA membranes (CON: 1,949±220 pmol/g wet wt; CHF: 797±231 pmol/g wet wt; P = 0.0001) and in LV membranes from animals with heart failure (CON: 1,719±308 pmol/g wet wt; CHF: 1,1 18±395 pmol/g wet wt; P = 0.008). These data support the findings obtained from the pertussis toxin-labeling studies.
Assessment of Gs. To determine whether diminution in adenylyl cyclase activity in myocardial membranes from paced animals was associated with decreased levels of cardiac Gs, we used three independent measures: cholera toxin-mediated ADP-ribosylation (Fig. 6 ), quantitative immunoblotting (Fig.  6) , and cyc-reconstitution assays (Fig. 7) . We found that chol- Membranes from control (n = 5) and CHF animals (n = 5) were studied simultaneously, stimulated with 13-receptor-dependent and GS-dependent agents, and cAMP production measured. In all cases, myocardium from CHF animals showed marked diminution in cAMP production.
Data represent cAMP produced in pmol/mg per min+ 1 SD, and are net values (basal subtracted). P = control vs CHF, two-tailed t test; ISO, 10
,gM isoproterenol; Gpp, 100 AM 5'-guanylyimidodiphosphate; NaF, 10 mM sodium fluoride; Forsk, 100 1AM forskolin. era toxin-catalyzed incorporation of 32P was lower in RA membranes (CON: 7.3±2.2 pmol/g wet wt; CHF: 5.4±0.6 pmol/g wet wt; P < 0.07) and in LV membranes from paced pigs (CON: 16.2±2.9 pmol/g; CHF: 12.3±1.8 pmol/g; P = 0.01).
Pacing-induced
As an independent, and more quantitative assay for the assessment of the amount of Gsa in cardiac membranes, we used immunoblotting (Fig. 6 ) which showed that the quantity of Gs was reduced in RA membranes (CON: 447±64 pmol/g wet wt; CHF: 320±64 pmol/g wet wt; P = 0.007) and in LV membranes from animals with heart failure (CON: 780±69 pmol/g wet wt; CHF: 625±121 pmol/g wet wt; P = 0.01). These data support the findings obtained from the cholera toxin-labeling studies.
To determine if reduced amounts ofGs, as indicated by the ADP-ribosylation and immunoblotting studies, were associated with reduced function ofGs, thereby contributing to the diminution in adenylyl cyclase activity, we performed reconstitution assays using cholate extracts (Gs-rich) from RA and LV membranes (Fig. 7) . Aluminum fluoride stimulation (Gs-dependent) of sarcolemmal membrane extracts from paced animals was decreased both in RA and in LV membranes, suggesting that Gs function was decreased after the development of CHF. For example, the amount of RA sarcolemmal protein required for 10 pmol/ 10 min cAMP production (Fig. 7) was greater after the development ofCHF: (CON: 85 ,ug; CHF: 1 10 ,ug). The amount of LV sarcolemmal protein required for 10 pmol/ 10 min cAMP production (Fig. 7) was also greater after the development of CHF: (CON: 58 ,g; CHF: 140 Ag). These data support the ADP-ribosylation data and the immunoblots, and extend the paradigm further: not only is the amount ofGs decreased in both chambers, but the function is decreased as well.
Assessment of the distribution of Gs between supernatant (presumably cytosolic) and pellet (presumably membrane-associated) fractions of the myocardial homogenates was performed (Fig. 8) . These homogenates as assessed by cholera toxin-labeling (CON: 51±7%; CHF: 63±6%; P = 0.0097). After heart failure, an increased proportion (35±5% increase; P = 0.005) of Gs was found in the supernatant fraction of LV homogenates as assessed by immunoblotting (data not shown). These data suggest a redistribution of Gs from the membrane fraction to the cell cytosol during the development of CHF.
Northern blotting. Fig. 9 shows Northern blots performed to assess steady state levels of Gsa mRNA from RA and LV membranes from control and CHF animals. Densitometry was used to assess the autoradiographs, and data are reported in arbitrary units which reflect blot density. LV levels of Gsa mRNA were unchanged by heart failure (CON: 6,306±337; CHF: 6,121±1,888). In contrast, RA levels of Gsa mRNA were increased in animals with heart failure (CON: 6,802±1,355; CHF: 9,127±46; P < 0.04).
Discussion
This study provides three new findings regarding CHF. First, pacing-induced CHF is associated with striking alterations in multiple elements of the fAR-G-protein-adenylyl cyclase pathway in both RA and LV membranes. Myocardial 3AR downregulation is found, which is similar in magnitude in both chambers. In addition, multiple measures of adenylyl cyclase activity, whether stimulated through the ,BAR, Gs, or directly through the catalytic subunit, are depressed. Both heart rate responsiveness and LV systolic function, measured in nonsedated conscious animals for the first time, were depressed, providing physiological correlates for biochemical evidence of depressed signal transduction through the ,3AR-G-protein-adenylyl cyclase pathway. Second, two independent measures of Gi showed this signal transducing protein is decreased in this model of heart failure in both RA and LV. The precise mechanism for downregulation of cardiac Gi was not established. However, downregulation of cardiac Gi in conjunction with marked depression of f3AR-mediated signal transduction suggests that increased Gi is not a necessary component for heart failure. Third, cardiac Gs, measured by three independent methods, was decreased in both RA and LV in animals with CHF. Since steady state levels of Gsa mRNA were not decreased, it is likely that reduced Gs reflects increased degrada- SARCOLEMMAL PROTEIN (micrograms) Figure 7 . Reconstitution of Gs into cyc-lymphoma cell membranes. (A) Cholate extracts (Gs rich) of right atrial membrane homogenates were stimulated (aluminum fluoride, 10 mM) and cAMP production was measured. Reconstituted Gs activity was decreased in right atrial membranes from animals with congestive heart failure (CHF). (B) Cholate extracts (Gs rich) of left ventricular membrane homogenates were stimulated (aluminum fluoride, 10 mM) and cAMP production was measured. Reconstituted Gs activity was decreased in left ventricular membranes from animals with congestive heart failure. Points represent mean± 1 SD from each group (n = 6, both groups). In all assays, no cAMP activity was detected when extract was not added (corresponding to 0,0 coordinates on the graphs). For simplicity, this point is shown as a clear circle only, but was included in the linear regression analyses for all assays.
tion rather than decreased synthesis of Gs. An increased proportion of Gs was found in the supernatant from RA and LV membrane homogenates from paced animals, suggesting that f3-adrenergic receptor activation by catecholamines, with subsequent redistribution of cardiac Gs to the cell cytosol, may be a mechanism by which Gs is downregulated in this model. This is the first study to provide data suggesting a possible mechanism for cardiac Gs downregulation in vivo. Myocardial fAR and adenylyl cyclase activity. Although no previous study has addressed alterations in 3AR-mediated signal transduction in pacing-induced CHF in pigs, two prior studies using this model in dogs have been published (6, 7 (34) . Other data suggest that the ,3y dimer, rather than dissociated ai, may lead to inhibition of adenylyl cyclase, either through direct interaction with the catalytic subunit, or through associating with free Gsa, thereby preventing Gsa-mediated stimulation of adenylyl cyclase (35 However, right atrial Gsa mRNA levels were significantly increased (P < 0.04) after pacing-induced CHF. ( 19, (40) (41) (42) . Inconsistent data may reflect differences between species, etiology of heart failure, or the added influence of prolonged pharmacological treatment, present in human, but not animal models. In the current study we used pacing-induced CHF, a much used animal model of CHF that allows detailed biochemical and molecular studies. Animals were not treated with pharmacological agents, and had a uniform etiology for CHF. Cardiac Gs content. Decreased cardiac Gs was demonstrated in both chambers by three independent means ofevaluation. The functional consequence of decreased levels of Gs were established in cyc-reconstitution assays. Other studies of animal models of heart failure or circulatory congestion have reported that cardiac Gs is decreased ( 19, 42) but there has not been uniform agreement. Human heart failure has been associated with no change ( 15) , or decreased levels of cardiac Gs (42) (43) (44) . We have found recently that when myocardial Gs content is measured in assays that use routine tissue preparation methods, a substantial portion oftotal Gs is discarded with the supernatant fraction after centrifugation (45). Indeed, both cholera toxin labeling and immunoblotting shows that up to 50% of the total Gs distributes to the supernatant. We have previously shown that the supernatant activity is not caused by membrane contamination ofthe supernatant (45). Redistribution ofGsa to the cell cytosol after receptor activation has been reported in isolated cell models (46). The current study, for the first time, provides evidence that Gs redistribution may represent an important mechanism by which Gs is downregulated after sustained f3AR activation in vivo. RA and LV membranes from paced animals showed not only downregulation of Gs, but an increased proportion of Gs in the supernatant. These data are consistent with the hypothesis that persistent catecholamine stimulation of f3-adrenergic receptors, as seen in heart failure, may lead to redistribution ofGs to the cell cytosol, and perhaps then to degradation. The decrease in Gs, shown by three independent methods of measuring Gs, coupled with the fact that steady state levels of Gsa mRNA are increased (RA) or unchanged (LV), suggests that increased Gs degradation rather than decreased Gs synthesis is the mechanism by which Gs is downregulated in this model of heart failure. Until quantitation of Gsa mRNA transcription rate and mRNA stability can be made, the conclusion that transcriptional regulation is not involved in reduced Gsa expression in heart failure must be restrained. Furthermore, the possibility that translational modifications may be of mechanistic importance in reduced G-protein expression has not been excluded.
In lymphoma cells the stoichiometry of elements of the flAR-Gs-adenylyl cyclase complex suggests that levels of Gs exceed both 3AR number and levels ofadenylyl cyclase (47) . If the porcine cardiac myocyte also has "spare" Gs, could a 20-27% decrease in Gs, as we report here, have biological meaning? We previously found that a 42% increase in RA Gs was associated with a 57% increase in the efficacy of isoproterenol to stimulate heart rate, suggesting that levels ofcardiac Gs may determine signal transduction efficiency ( 12) . In heart failure, therefore, even though the amounts of adenylyl cyclase and ,BAR number may set limits upon maximal responsiveness, a decreased amount of Gs, albeit small, may further impair signal transduction efficiency. Only one prior study has examined cardiac Gs in a canine model of pacing-induced heart failure (7). They found no change in Gs function as assessed by reconstitution assays conducted on LV membranes. While there may be a species difference in Gs response in this model of heart failure, we are impressed with the similarities in ,BAR expression and adenylyl cyclase activity between these species.
Immunoblotting vs ADP ribosylation. The amounts ofGia2 and Gs a as measured by quantitative immunoblotting is 60-100-fold greater than the amount of pertussis toxin or cholera toxin substrates (Figs. 5 and 6 ). Since membrane preparations for these studies were identical, this suggests that bacterial toxin substrates are less accessible to ADP-ribosylation than Gia2 and Gs a are to interaction with specific antibodies. It is of interest that despite these striking differences in quantitative capacity, both techniques (ADP ribosylation and immunoblotting) yield very similar relative changes in Gi and Gs in CHF. No prior studies have provided quantitative data expressed as activity per gram of tissue using both immunoblotting and ADP ribosylation in the heart. The activity of Gs per milligram protein that we find by quantitative immunoblotting is very similar to the amount that we previously reported by ELISA ( 12) . Similar values obtained by two different techniques provide a high level of confidence in the quantitative capacity of our measurements.
Implications ofthe data. A word of caution is in order regarding the application of these data to the pathophysiology of heart failure. In a previous study we used aortocaval fistulas to induce volume overload and a congested circulatory state ( 19) . This model is characterized by high cardiac output, normal cardiac function, and high plasma catecholamines. Despite normal cardiac performance, the volume-overloaded congested state was associated with abnormalities in myocardial OAR expression, adenylyl cyclase activity, and Gs function which are almost identical to the findings of the present study. Thus, in two models with striking differences in LV function, elements of the fAR-Gs-adenylyl cyclase pathway are almost identical. This implies that the primary lesion in pacing-induced heart failure (and perhaps other models of dilated, systolic heart failure) is distal to adenylyl cyclase activation.
Perhaps the contractile apparatus itself, or activation of sarcoplasmic reticulum calcium channels is abnormal in pacing-induced CHF. Recent data suggest that sustained agonist stimulation can result in decreased amounts of phospholamban (48), a key sarcoplasmic reticulum protein which regulates the Ca2+-ATPase channel. This implies that alterations in cell surface receptor number and adenylyl cyclase activity may simply reflect homeostatic adjustments secondary to sustained sympathetic activation, rather than being of primary mechahistic importance in the pathogenesis of heart failure.
Conclusions. There are striking similarities between human dilated cardiomyopathy and pacing-induced heart failure in pigs. Both types of heart failure are associated with cardiac dilatation, increased plasma and decreased myocardial catecholamine contents, and downregulation of myocardial fARs and adenylyl cyclase activity. However, unlike human heart failure, where increased cardiac Gi is found, Gi is downregulated in pacing-induced heart failure. Thus, levels of cardiac Gi alone are not predictive ofadrenergic responsiveness or cardiac function in heart failure. Reduced levels of cardiac Gs are associated with increased (RA) or unchanged (LV) steady state levels of Gsa mRNA in pacing-induced heart failure, suggesting that reduced Gs may reflect increased Gsa degradation rather than decreased Gsa synthesis. An important step in Gs degradation may be redistribution of Gsa to the cell cytosol after,BAR activation. The remarkably similar alterations in the ,BAR-Gs-adenylyl cyclase pathway in pacing-induced heart failure (poor LV function) and circulatory congestion induced by aorto-caval fistula (normal LV function) underscores the importance ofintracellular events beyond the activation ofcell surface receptors as fundamental determinants of contractile function.
